Suppr超能文献

低剂量孕激素疗法(作者译)

[The low dosis gestagen therapy (author's transl)].

作者信息

Mall-Haefeli M, Ludwig K S, Spornitz U M, Uettwiller A

出版信息

Geburtshilfe Frauenheilkd. 1976 Aug;36(8):645-60.

PMID:976705
Abstract

In young women aged 22-34 years the hormone profile under continuous therapy with 0.5 mg lynestrenol/day have been investigated. Estradiol, progesterone and FSH values have been determined in plasma by the RIA or protein-binding method, whereas LH excretion was daily measured in the urine starting on the 5th day of cycle. The low-dose-gestagen therapy shows all possible hormonal patterns ranging from the ovulatory to anovulatory one. The estradiol-17 B values in half of the patients were higher than in the cycle preceding treatment. In the first few treatment cycles all women showed markedly decreased progesterone values. However, this defect seems to recover and return to normal in later cycles. In order to be able to further explain the alterations occurring during the luteal phase under the treatment with 0.5 mg/day of lynestrenol, ovarian tissues wedge resection of women undergoing gynecological surgery has been examined macroscopically and microscopically. At the same time the hormonal profile has been determined in plasma. These investigations revealed that the morphological alterations in the ovary proceed in an unchanged way under the mentioned treatment. Histologically it could be demonstrated that ovulation is delayed by several days. The histological findings of tubal tissue (from patients who underwent sterilization) showed that the secretional activity of the tubal epithelium is considerably decreased and ciliogenesis increased. In our clinical study neither tablet nor patient failures occurred. With the exception of cycle- and tempo-disturbances no severe adverse reactions were reported. Breakthrough bleedings and spotting as well as amenorrhea in most cases manifested already in the first treatment cycles. It is important that the daily tablet is taken at midday because the maximum effect on the cervical mucus of the mini-pill therapy is most pronounced 4-6 hours after tablet intake. Especially in young patients it is recommended to get written reports on tablet intake. The strict following of these directions mainly guarantees a successful mini-pill therapy.

摘要

对年龄在22 - 34岁的年轻女性进行了研究,她们每天持续服用0.5毫克炔诺酮。通过放射免疫分析(RIA)或蛋白结合法测定血浆中的雌二醇、孕酮和促卵泡激素(FSH)值,而从周期的第5天开始每天测量尿中的促黄体生成素(LH)排泄量。低剂量孕激素疗法显示出从排卵型到无排卵型的所有可能的激素模式。一半患者的雌二醇-17β值高于治疗前的周期。在最初的几个治疗周期中,所有女性的孕酮值均明显下降。然而,这种缺陷在随后的周期中似乎有所恢复并恢复正常。为了能够进一步解释在每天服用0.5毫克炔诺酮治疗期间黄体期发生的变化,对接受妇科手术的女性的卵巢组织楔形切除术进行了宏观和微观检查。同时测定了血浆中的激素谱。这些研究表明,在上述治疗下,卵巢的形态学改变以不变的方式进行。组织学上可以证明排卵延迟了几天。输卵管组织(来自接受绝育手术的患者)的组织学发现表明,输卵管上皮的分泌活性明显降低,纤毛形成增加。在我们的临床研究中,未发生药片或患者失败的情况。除了周期和节律紊乱外,未报告严重的不良反应。突破性出血、点滴出血以及闭经在大多数情况下在第一个治疗周期就已出现。重要的是每天的药片要在中午服用,因为短效口服避孕药疗法对宫颈黏液的最大作用在服药后4 - 6小时最为明显。尤其对于年轻患者,建议获取关于服药情况的书面报告。严格遵循这些指示主要可确保短效口服避孕药疗法取得成功。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验